FIELD: medicine, biochemistry.
SUBSTANCE: invention relates to method for determination of peroxide group content in lipids containing in biological fluids. Claimed method includes sampling of tested fluid, extraction of organic components by sample treatment with 3-fold amount of chloroform as solvent. After extraction solvent is vaporized in inert gas flow , further total amount of lipids is determined by gravimetric analysis. Then sample is treated with glacial acetic acid up to total protein deposition in flake form. Then reagent mixture comprising KJ and CH3COOH in ratio of 1.0-1.5 l CH3COOH per 100 g KJ is introduced into tested sample to provide redox-interaction with globulated protein molecules up to total iodine reducing. Sample is placed in dark room for 1.5-2 h and further released iodine amount is determined by titrimetric method. And on the base of obtained data peroxide group content in lipids is determined.
EFFECT: simplified and accelerated method.
9 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MEASURING MASS CONCENTRATION OF METHYL ESTERS OF FATTY ACIDS IN BIOLOGICAL MEDIA BY GAS-LIQUID CHROMATOGRAPHY METHOD | 2020 |
|
RU2758932C1 |
METHOD FOR DETERMINATION OF SPHINGOMYELYN CONTENT IN BIOLOGICAL FLUIDS | 0 |
|
SU1663554A1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD OF STABILISING LIPIDS OF FISH FEED | 2010 |
|
RU2457240C2 |
METHOD OF DETERMINING GLUCOSE USING POLYMETHACRYLATE MATRIX | 2023 |
|
RU2826378C1 |
METHOD OF DETERMINING CONTENT OF LIPID PEROXIDES IN FOOD PRODUCTS | 0 |
|
SU1003648A1 |
METHOD OF DETERMINING O-TOLUIDINE IN BLOOD | 1991 |
|
RU2023258C1 |
METHOD FOR DETERMINING LOSARTAN, ITS MAIN METABOLITE LOSARTAN CARBOXYLIC ACID AND GLIBENCLAMIDE IN HUMAN BLOOD SERUM AND URINE | 2020 |
|
RU2749567C1 |
METHOD OF SAMPLE PREPARATION OF BIOLOGICAL SAMPLES FOR QUANTITATIVE DETERMINATION OF IODINE | 2023 |
|
RU2808066C1 |
EXPRESS METHOD FOR DETERMINING CEFTRIAXONE IN BLOOD PLASMA AND MIXED SALIVA OF COVID-19 PATIENTS | 2021 |
|
RU2771851C1 |
Authors
Dates
2007-02-10—Published
2005-04-11—Filed